Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 120

1.
2.

Botulinum toxin type A (BOTOX) for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

Mathew NT, Frishberg BM, Gawel M, Dimitrova R, Gibson J, Turkel C; BOTOX CDH Study Group.

Headache. 2005 Apr;45(4):293-307.

PMID:
15836565
3.
4.

OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.

Aurora SK, Winner P, Freeman MC, Spierings EL, Heiring JO, DeGryse RE, VanDenburgh AM, Nolan ME, Turkel CC.

Headache. 2011 Oct;51(9):1358-73. doi: 10.1111/j.1526-4610.2011.01990.x. Epub 2011 Aug 29.

PMID:
21883197
5.
6.

Botulinum toxin type A for the prophylactic treatment of chronic daily headache: a randomized, double-blind, placebo-controlled trial.

Silberstein SD, Stark SR, Lucas SM, Christie SN, Degryse RE, Turkel CC; BoNTA-039 Study Group.

Mayo Clin Proc. 2005 Sep;80(9):1126-37.

PMID:
16178492
7.

OnabotulinumtoxinA for chronic migraine: efficacy, safety, and tolerability in patients who received all five treatment cycles in the PREEMPT clinical program.

Aurora SK, Dodick DW, Diener HC, DeGryse RE, Turkel CC, Lipton RB, Silberstein SD.

Acta Neurol Scand. 2014 Jan;129(1):61-70. doi: 10.1111/ane.12171. Epub 2013 Sep 20.

8.

Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.

Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM; BOTOX North American Episodic Migraine Study Group.

Headache. 2007 Apr;47(4):486-99.

PMID:
17445098
9.

Pericranial injection of botulinum toxin type A (Dysport) for tension-type headache - a multicentre, double-blind, randomized, placebo-controlled study.

Straube A, Empl M, Ceballos-Baumann A, Tölle T, Stefenelli U, Pfaffenrath V; Dysport Tension-Type Headache Study Group.

Eur J Neurol. 2008 Mar;15(3):205-13. doi: 10.1111/j.1468-1331.2007.02051.x.

PMID:
18290842
10.

Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study.

Sandrini G, Perrotta A, Tassorelli C, Torelli P, Brighina F, Sances G, Nappi G.

J Headache Pain. 2011 Aug;12(4):427-33. doi: 10.1007/s10194-011-0339-z. Epub 2011 Apr 16.

11.

Chronic daily headache prophylaxis with tizanidine: a double-blind, placebo-controlled, multicenter outcome study.

Saper JR, Lake AE 3rd, Cantrell DT, Winner PK, White JR.

Headache. 2002 Jun;42(6):470-82.

PMID:
12167135
13.

A double-blind comparison of onabotulinumtoxina (BOTOX) and topiramate (TOPAMAX) for the prophylactic treatment of chronic migraine: a pilot study.

Mathew NT, Jaffri SF.

Headache. 2009 Nov-Dec;49(10):1466-78. doi: 10.1111/j.1526-4610.2009.01566.x.

PMID:
19912346
14.

Botulinum toxin type B in upper-limb poststroke spasticity: a double-blind, placebo-controlled trial.

Brashear A, McAfee AL, Kuhn ER, Fyffe J.

Arch Phys Med Rehabil. 2004 May;85(5):705-9.

PMID:
15129392
15.

Botulinum toxin type A in prophylactic treatment of migraine.

Anand KS, Prasad A, Singh MM, Sharma S, Bala K.

Am J Ther. 2006 May-Jun;13(3):183-7.

PMID:
16772757
16.

Botulinum toxin type-a in the prevention of migraine: a double-blind controlled trial.

Vo AH, Satori R, Jabbari B, Green J, Killgore WD, Labutta R, Campbell WW.

Aviat Space Environ Med. 2007 May;78(5 Suppl):B113-8.

PMID:
17547312
17.

A multi-center double-blind pilot comparison of onabotulinumtoxinA and topiramate for the prophylactic treatment of chronic migraine.

Cady RK, Schreiber CP, Porter JA, Blumenfeld AM, Farmer KU.

Headache. 2011 Jan;51(1):21-32. doi: 10.1111/j.1526-4610.2010.01796.x. Epub 2010 Nov 10.

PMID:
21070228
18.

Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.

Silberstein SD, Lipton RB, Dodick DW, Freitag FG, Ramadan N, Mathew N, Brandes JL, Bigal M, Saper J, Ascher S, Jordan DM, Greenberg SJ, Hulihan J; Topiramate Chronic Migraine Study Group.

Headache. 2007 Feb;47(2):170-80.

PMID:
17300356
19.

Botulinum toxin a in the treatment of chronic tension-type headache with cervical myofascial trigger points: a randomized, double-blind, placebo-controlled pilot study.

Harden RN, Cottrill J, Gagnon CM, Smitherman TA, Weinland SR, Tann B, Joseph P, Lee TS, Houle TT.

Headache. 2009 May;49(5):732-43. doi: 10.1111/j.1526-4610.2008.01286.x. Epub 2008 Oct 24.

PMID:
19178577
20.

OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.

Silberstein SD, Blumenfeld AM, Cady RK, Turner IM, Lipton RB, Diener HC, Aurora SK, Sirimanne M, DeGryse RE, Turkel CC, Dodick DW.

J Neurol Sci. 2013 Aug 15;331(1-2):48-56. doi: 10.1016/j.jns.2013.05.003. Epub 2013 Jun 19.

PMID:
23790235

Supplemental Content

Support Center